Zentalis Pharmaceuticals (ZNTL) Interest Coverage Ratio Growth (3y) (2022 - 2026)
Zentalis Pharmaceuticals (ZNTL) Interest Coverage Ratio Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - | -42.41% |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | - |
| 4 | BeOne Medicines | 472.68 Bn | 467.89 Bn | 1.35 Bn | 28.11% |
| 5 | Vertex Pharmaceuticals | 122.24 Bn | 114.99 Bn | 2.59 Bn | -6.89% |
| 6 | Regeneron Pharmaceuticals | 70.08 Bn | 61.33 Bn | 3.31 Bn | 79.27% |
| 7 | Belite Bio | 62.46 Bn | 62.46 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.75 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.59 Bn | 34.58 Bn | 959.66 Mn | 40.09% |
| 10 | Zentalis Pharmaceuticals | 316.19 Mn | 316.19 Mn | - | 34.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.66% |
| Sep 30, 2025 | -46.06% |
| Jun 30, 2025 | 59.25% |
| Mar 31, 2025 | 55.01% |
| Sep 30, 2024 | 65.83% |
| Jun 30, 2024 | 72.09% |
| Mar 31, 2024 | 76.95% |
| Dec 31, 2023 | -145.78% |
| Sep 30, 2023 | 61.58% |
| Jun 30, 2023 | 49.31% |
| Mar 31, 2023 | 24.79% |
| Mar 31, 2022 | 77.29% |